Daewoong Pharmaceutical Co., Ltd (KRX:069620)
South Korea flag South Korea · Delayed Price · Currency is KRW
120,800
+1,600 (1.34%)
At close: Mar 25, 2025, 3:30 PM KST

Daewoong Pharmaceutical Revenue

In the year 2024, Daewoong Pharmaceutical had annual revenue of 1.42T KRW with 3.44% growth. Daewoong Pharmaceutical had revenue of 367.88B in the quarter ending December 31, 2024, with 1.67% growth.

Revenue
1,422.68B
Revenue Growth
+3.44%
P/S Ratio
0.94
Revenue / Employee
823.79M
Employees
1,727
Market Cap
1,340.48B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20241,422.68B47.35B3.44%
Dec 31, 20231,375.33B95.24B7.44%
Dec 31, 20221,280.09B127.12B11.03%
Dec 31, 20211,152.98B97.55B9.24%
Dec 31, 20201,055.42B-58.00B-5.21%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition